Royal Bank of Canada’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.24M | Buy |
|
|||||
|
2025
Q2 | $678K | Buy |
|
|||||
|
2025
Q1 | $24K | Sell |
|
|||||
|
2024
Q4 | $34K | Sell |
|
|||||
|
2024
Q3 | $91K | Sell |
|
|||||
|
2024
Q2 | $129K | Buy |
|
|||||
|
2024
Q1 | $159K | Sell |
|
|||||
|
2023
Q4 | $429K | Buy |
|
|||||
|
2023
Q3 | $330K | Buy |
|
|||||
|
2023
Q2 | $242K | Buy |
|
|||||
|
2023
Q1 | $161K | Sell |
|
|||||
|
2022
Q4 | $652K | Sell |
|
|||||
|
2022
Q3 | $935K | Buy |
|
|||||
|
2022
Q2 | $879K | Sell |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $1.63M | Buy |
|
|||||
|
2021
Q3 | $2.13M | Sell |
|
|||||
|
2021
Q2 | $3.54M | Buy |
|
|||||
|
2021
Q1 | $2.12M | Sell |
|
|||||
|
2020
Q4 | $8.41M | Buy |
|
|||||
|
2020
Q3 | $1.75M | Sell |
|
|||||
|
2020
Q2 | $1.93M | Buy |
|
|||||
|
2020
Q1 | $1.16M | Buy |
|
|||||
|
2019
Q4 | $1.69M | Sell |
|
|||||
|
2019
Q3 | $1.49M | Buy |
|
|||||
|
2019
Q2 | $1.62M | Buy |
|
|||||
|
2019
Q1 | $1.5M | Buy |
|
|||||
|
2018
Q4 | $1.17M | Sell |
|
|||||
|
2018
Q3 | $1.72M | Buy |
|
|||||
|
2018
Q2 | $1.94M | Buy |
|
|||||
|
2018
Q1 | $1.25M | Buy |
|
|||||
|
2017
Q4 | $619K | Buy |
|
|||||
|
2017
Q3 | $333K | Buy |
|
|||||
|
2017
Q2 | $157K | Buy |
|
|||||
|
2017
Q1 | $201K | Buy |
|
|||||
|
2016
Q4 | $105K | Buy |
|
|||||
|
2016
Q3 | $40K | Buy |
|
|||||
|
2016
Q2 | $13K | Sell |
|
|||||
|
2016
Q1 | $164K | Buy |
|